Coherent’s Mixed Signals: Record Results Met With Market Skepticism

Despite posting record annual figures and securing a major strategic partnership with Apple, Coherent’s investors were left with a sense of uncertainty following its recent earnings release. The market’s reaction was decisively negative, raising questions about why a photonics leader delivering impressive results is facing such a harsh judgment.

A Cautious Outlook Overshadows Strong Performance

The market trades on future expectations, not past successes. This reality hit Coherent hard on August 13. While the company unveiled what appeared to be stellar annual results—a 23% surge in revenue to $5.81 billion and an adjusted earnings per share that nearly tripled to $3.53—its forward guidance disappointed. The company’s sales forecast for the current quarter, projected between $1.46 billion and $1.60 billion, fell short of analyst expectations. The immediate response was a swift 18% decline in after-hours trading.

Strategic Moves to Sharpen Focus

Alongside its financial data, Coherent announced two significant strategic developments. In a move to sharpen its focus on core markets and reduce debt, the company agreed to sell its Aerospace and Defence business to private equity firm Advent for $400 million. Potentially more impactful was the expansion of its existing partnership with tech giant Apple. A new multi-year contract ensures Coherent will remain a key supplier, providing VCSEL lasers for Face ID systems manufactured at its Sherman, Texas facility.

Should investors sell immediately? Or is it worth buying Coherent?

Analyst Confidence Remains High

The near-term disappointment did little to dampen the long-term optimism from market analysts. Several firms reaffirmed or raised their positive ratings, indicating strong belief in Coherent’s strategic direction. Stifel increased its price target from $100 to $118 while maintaining a Buy recommendation. Raymond James was even more bullish, boosting its target from $120 to $134 and reiterating a Strong Buy rating. This sentiment was echoed by Rosenblatt ($135 target) and Needham ($120 target), which both confirmed their Buy endorsements. The average analyst price target now stands at $110, signaling a moderate Buy consensus.

The central question remains whether Coherent can translate its strategic positioning into sustained performance that meets these high expectations. The foundation has been laid; the company must now execute.